Alberto M. Pedroncelli

Alberto M. Pedroncelli has extensive experience in the pharmaceutical industry. Alberto M.'smost recent position was as the Chief Medical Officer at Camurus starting in June 2023. Prior to that, they served as the Head of Clinical Development and Medical Affairs - Endocrinology at Recordati Rare Diseases from April 2020 to May 2023. Before their time at Recordati, Alberto held various roles at Novartis Oncology, including Sr. Global Programme Clinical Head - Rare Disease, GMA Sr Franchise Head - Rare Disease, Sr Global Brand Medical Director - Rare Disease, Global Brand Medical Director - Rare Disease, and Sr. Clinical Research Manager. Alberto M.'stenure at Novartis spanned from May 2006 to April 2020.

Alberto M. Pedroncelli has attended Università degli Studi di Milano for an unspecified period of time. However, there is no information available about the specific degree or field of study pursued during their time at the institution.